activation and specificity of CD8+ T cells and thus are important for devising T-cell
immunotherapies. In recent times, advances in mass spectrometry (MS) have enabled the
precise identification of these MHC-I peptides, wherein MS spectra are compared against a
reference proteome. Unfortunately, matching these spectra to reference proteome
databases is hindered by inflated search spaces attributed to a lack of enzyme restriction in …